Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Should Rx Patient Leaflets Be Labeled Like Dietary Supplements?

This article was originally published in The Pink Sheet Daily

Executive Summary

If patient medication information documents noted when they were not FDA approved, it might relieve some pre-marketing review burden on the agency, but officials worry consumers will not trust the information.

You may also be interested in...



Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets

Manufacturers would have full responsibility for writing, producing, and ultimately delivering the new patient medication information document with their products, if FDA decides the industry should fully adopt the unit-of-use packaging.

Assurance Vs. Flexibility: Unit-Of-Use Packaging Offers Trade-Offs For Patient Leaflets

Manufacturers would have full responsibility for writing, producing, and ultimately delivering the new patient medication information document with their products, if FDA decides the industry should fully adopt the unit-of-use packaging.

FDA Must Maintain Oversight Role In PMI Development, Groups Urge

Advocates argue patient medication information documents could resemble advertising if FDA does not review and approve them before they are used, regardless of resources concerns.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel